Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
about
Expression of GATA3 in MDA-MB-231 triple-negative breast cancer cells induces a growth inhibitory response to TGFßInhibition of transforming growth factor-beta1-induced signaling and epithelial-to-mesenchymal transition by the Smad-binding peptide aptamer Trx-SARAMesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancersInflammatory microenvironment contributes to epithelial-mesenchymal transition in gastric cancerEpithelial-Mesenchymal Transition and Breast CancerMolecular mechanisms of epithelial-mesenchymal transitionPy2T murine breast cancer cells, a versatile model of TGFβ-induced EMT in vitro and in vivoRole of TGFβ in regulation of the tumor microenvironment and drug delivery (review)TGFβ Signaling in Tumor Initiation, Epithelial-to-Mesenchymal Transition, and MetastasisJDP2 inhibits the epithelial-to-mesenchymal transition in pancreatic cancer BxPC3 cells14-3-3σ Gene Loss Leads to Activation of the Epithelial to Mesenchymal Transition Due to the Stabilization of c-Jun ProteinA review of the past, present, and future directions of neoplasiaComing of Age in the Life ofNeoplasia: Where We Have Been and Where We Are GoingCurcumin inhibits transforming growth factor-β1-induced EMT via PPARγ pathway, not Smad pathway in renal tubular epithelial cellsResveratrol inhibits cisplatin-induced epithelial-to-mesenchymal transition in ovarian cancer cell linesTGF-beta-induced epithelial to mesenchymal transitionGlutamatergic signaling maintains the epithelial phenotype of proximal tubular cells.TGF-β regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion.Genes involved in TGF beta1-driven epithelial-mesenchymal transition of renal epithelial cells are topologically related in the human interactome mapComplete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathwayLosartan inhibits endothelial-to-mesenchymal transformation in mitral valve endothelial cells by blocking transforming growth factor-β-induced phosphorylation of ERK.SMAD4 loss triggers the phenotypic changes of pancreatic ductal adenocarcinoma cellsThe complex interplay between ERK1/2, TGFβ/Smad, and Jagged/Notch signaling pathways in the regulation of epithelial-mesenchymal transition in retinal pigment epithelium cells.The tale of transforming growth factor-beta (TGFbeta) signaling: a soigné enigma.Suppression of Hepatic Epithelial-to-Mesenchymal Transition by Melittin via Blocking of TGFβ/Smad and MAPK-JNK Signaling Pathways.Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation.Gambogic acid suppresses cancer invasion and migration by inhibiting TGFβ1-induced epithelial-to-mesenchymal transitionRole of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cellsSmall molecules, big roles -- the chemical manipulation of stem cell fate and somatic cell reprogramming.Mechanisms of the epithelial-mesenchymal transition by TGF-betaProgression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.The interaction of LFA-1 on mononuclear cells and ICAM-1 on tubular epithelial cells accelerates TGF-β1-induced renal epithelial-mesenchymal transitionBioinformatic approaches to augment study of epithelial-to-mesenchymal transition in lung cancerHistone deacetylase 1 and 2 differentially regulate apoptosis by opposing effects on extracellular signal-regulated kinase 1/2High throughput kinase inhibitor screens reveal TRB3 and MAPK-ERK/TGFβ pathways as fundamental Notch regulators in breast cancer.A molecular signature of normal breast epithelial and stromal cells from Li-Fraumeni syndrome mutation carriers.Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transitionTransforming growth factor-β and the hallmarks of cancer.CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
P2860
Q21133567-D3233EE9-2FD2-4FDB-A959-05C47A37CEA5Q24671742-B452021B-B267-4544-9C20-F2A0E807DAC2Q24674085-AAF1E477-4828-4A4C-A8F7-3EFA447333AAQ26740208-AC246DAE-B1F2-466C-BCCA-F22FA12E6DBEQ26773055-52A2F806-042C-42EA-AD0C-A480C24C7EB2Q27013743-E5F9FD2B-66B1-492A-8234-390591937739Q27340972-3C4E8145-4AEB-4B78-B1DB-AAB6C30AC657Q28081170-231A584C-DD44-439A-B38E-2ABFE794F9BCQ28083107-F0818EF7-2DAB-47FF-8657-55E2A74A2F25Q28265314-80FF22C7-20C8-42B7-BF9E-B46D13E598A1Q28385396-0E54764F-C595-4A18-92F3-2B2812B125D5Q28389391-86EB5238-E06E-4C5D-9655-A1BC8E152ED9Q28389985-0BDBF290-1B6B-4B0B-B6D9-48153283504FQ28395095-5AFC4211-B09A-42C9-BCC3-602ECB91FD29Q28489058-F5FB421C-7DC5-46D9-B72E-EA697C3DA4E1Q28539044-AB98A9A7-50AD-423D-A82E-810CCD47526EQ29619820-44253DBC-F094-4275-A679-17B6F6FAFD84Q30500628-F38E7C23-6E72-435F-981E-9BE07CFE4964Q30597668-537EF6EE-9EE0-4718-B832-F45C85699FEEQ33303477-7F234B31-A516-4D64-933A-36D83EE5E542Q33520113-4EAAA912-1F68-43AA-AE06-05876840F3CAQ33555365-D3065093-566B-4251-860F-E31BD0DB9A15Q33556577-8562E698-9899-4716-A7B8-F36FD2B39CC4Q33560424-72455F93-877A-4A72-8FB7-410E07B11F8BQ33607396-70675DB8-7F84-437D-9AE3-1738AE178C50Q33612064-C8BF5C39-5DFB-4D5D-8136-A0D257BE43EFQ33670029-6F1F66AA-6365-4CDF-BBA5-F2075476F926Q33688954-43B7B597-DC74-40E9-9EE7-757A0D7BBE8BQ33694557-5F2D744A-F489-4900-ABE4-0AA68C3E516EQ33793268-07AFE58C-A0E9-4221-A523-385549642271Q33804105-9AE4B6FD-5DBF-4487-8431-B8521B567237Q33839230-733EC961-AD6A-47B3-93A0-90A16A66CF7CQ33995681-CDCA7367-707A-4820-A7C1-EC007025B2FAQ34295621-36FA02A5-4916-4C0D-BF93-F8EF44774017Q34545336-9A7A2664-99A8-46E6-B795-3BFF93CA5643Q34548034-ACDE4E7A-A74A-49D7-A3B1-CBDC345D8849Q34575966-C8AB3F59-F267-415D-8B63-422343DD9666Q34623170-5DF4C72E-0D0E-418B-B5FC-077D7B998824Q34789300-1AC6139B-49F2-4E2B-A6DD-199A01536E53Q34984681-09DBFF19-FE63-4EB9-8D54-A5AC8586A873
P2860
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@ast
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@en
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@nl
type
label
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@ast
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@en
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@nl
prefLabel
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@ast
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@en
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@nl
P2093
P2860
P356
P1433
P1476
Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro
@en
P2093
Anna M Chytil
Brian K Law
Kimberly A Brown
Mary E Aakre
P2860
P304
P356
10.1593/NEO.04241
P577
2004-09-01T00:00:00Z